FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3094111000001103: Ointment (product)

  • Ointment

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
14614701000001114 Ointment (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
14614801000001117 Ointment en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Inbound Relationships Type Active Source Characteristic Refinability Group
Generic Antipeol ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Antazoline 2% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Fluocortolone 0.25% / Fluocortolone hexanoate 0.25% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic TCP antiseptic ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Maxitrol eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Levomenthol 0.3% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 6.6% / Lidocaine 0.7% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Gregoderm ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Ichthammol 10% ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 3 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Shark liver oil 3% / Yeast cell extract 1% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Sunscreen lip balm SPF 30 Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrous wool fat BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Simple ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc 15% ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc oxide 15% / Ichthammol 1% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Tri-Adcortyl ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Simple eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 25 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Allantoin 0.5% / Lidocaine 0.5% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Clioquinol 3% / Fluocinolone 0.025% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Neomycin 0.25% / Gramicidin 0.025% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely cod liver oil 114 milligram/1 gram and zinc oxide 380 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Salicylic acid 2% ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Bacitracin 500units/g eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polymyxin B sulfate+trimethoprim eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Methyl salicylate ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Polymyxin B 10,000units/g / Bacitracin 500units/g ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 100 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Cadexomer-iodine 0.9% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Benzoic acid compound ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Paraffin yellow soft BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Nystaform HC ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely framycetin sulfate 5 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Chlortetracycline 3.09% / Triamcinolone acetonide 0.1% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Betamethasone 0.1% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Paraffin white soft BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Emulsifying wax 30% / Yellow soft paraffin 30% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Lacrilube eye ointment preservative free Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Lubri-tears eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Zinc+castor oil ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Titanium ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Hydrous ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Cocois ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Sofradex eye/ear ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Anusol HC ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Anusol ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Ultraproct ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Tri-Adcortyl Otic ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Generic Dermovate-NN ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Cinchocaine 0.5% / Prednisolone 0.19% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Cinchocaine hydrochloride 0.5% / Hydrocortisone 0.5% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol 10 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Emulsifying ointment BP Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Ointment Inferred relationship Existential restriction modifier

Page 1 of 2 End

This concept is not in any reference sets

Back to Start